Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes. (Q51374688)

4 April 2018

title

Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes. (English)

1 reference

4 April 2018

0 references

0 references

9

1 reference

4 April 2018

Maria José Freire

object named as

Maria José Freire

6

0 references

Marta Guimarães

object named as

Marta Guimarães

2

0 references

author name string

Mário Nora

1

1 reference

4 April 2018

Rui Almeida

3

1 reference

4 April 2018

Paulo Martins

4

1 reference

4 April 2018

Gil Gonçalves

5

1 reference

4 April 2018

Tiago Ferreira

7

1 reference

4 April 2018

Cláudia Freitas

8

1 reference

4 April 2018

publication date

1 November 2011

1 reference

4 April 2018

published in

Obesity Surgery

1 reference

4 April 2018

volume

21

1 reference

4 April 2018

issue

11

1 reference

4 April 2018

page(s)

1643-1649

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s11695-011-0418-x

exact match

0 references

cites work

Global burden of obesity in 2005 and projections to 2030.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Diabetes in America: epidemiology and scope of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Overweight, obesity, and health risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Bariatric surgery for diabetes management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Mechanism for improved insulin sensitivity after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Incretins, diabetes, and bariatric surgery: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Complications after laparoscopic gastric bypass: a review of 3464 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Laparoscopic Roux-en-Y gastric bypass: results and learning curve of a high-volume academic program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-011-0418-X

Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes

21 January 2018

1 reference

12 December 2020

Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

Beneficial health effects of modest weight loss

1 reference

12 December 2020

Overweight and obesity in Portugal: national prevalence in 2003-2005.

1 reference

12 December 2020

Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss

1 reference

12 December 2020

Diabetes: the evolution of a new paradigm

1 reference

12 December 2020

Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes

1 reference

12 December 2020

10.1007/S11695-011-0418-X

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

21512818

1 reference

4 April 2018